Patent ID: 6348444
Filing Date: 2002-02-19
Classification: A61K,A61P

Abstract:
A method for stimulating hematopoiesis and immune reconstitution in human patients following hematopoietic stem cell transplantation, comprising the step of administering to a human patient not before about 30 days post-transplantation of hemopoietic stem cells a pharmaceutical composition comprising a pharmaceutically acceptable carrier, excipient, stabilizer or auxiliary agent, and an effective amount of the human growth hormone of SEQ ID NO:1 or a fragment, analog, variant or chemical derivative thereof, having the hematopoiesis stimulating activity of human growth hormone, as an active ingredient, with the proviso that the variant is not the 20 kDa human growth hormone variant lacking the 15 amino acid residues from Glu32 to Gln46 of SEQ ID NO:1.